This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An Open-Label, Multicenter, Phase I/II Clinical Tr...
Clinical trial

An Open-Label, Multicenter, Phase I/II Clinical Trial to Identify the Modufolin� Dose with Most Favorable Safety Prospect and Confirmed Ability to Mitigate High-Dose Methotrexate Induced Toxicity during Treatment of Osteosarcoma Patients

Read time: 1 mins
Last updated:9th Jul 2013
To characterize safety in terms of toxicity during HDMTX treatment and folate rescue therapy with either Modufolin� or Calcium Folinate. To identify the recommended dose of Modufolin� for further assessment.
Category Value
Study start date 2013-07-09

View full details